SNSE Latest Press Releases

-- March 17, 2026 --

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:00 AM

-- February 25, 2026 --

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:00 AM

-- February 18, 2026 --

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement Business Wire 8:00 AM

-- January 7, 2026 --

Egle Therapeutics Appoints John Celebi as Chief Executive Officer Globe Newswire 8:00 AM

-- November 14, 2025 --

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:30 AM

-- October 30, 2025 --

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value Globe Newswire 9:00 AM

-- October 17, 2025 --

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software